Solid Biosciences (SLDB) EPS (Basic) (2017 - 2024)
Historic EPS (Basic) for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to -$1.02.
- Solid Biosciences' EPS (Basic) fell 200.0% to -$1.02 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.06, marking a year-over-year increase of 3677.69%. This contributed to the annual value of -$3.06 for FY2024, which is 3664.6% up from last year.
- Solid Biosciences' EPS (Basic) amounted to -$1.02 in Q4 2024, which was down 200.0% from -$0.79 recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' EPS (Basic) registered a high of -$0.39 during Q2 2020, and its lowest value of -$6.17 during Q4 2020.
- Its 4-year average for EPS (Basic) is -$1.48, with a median of -$1.0 in 2023.
- As far as peak fluctuations go, Solid Biosciences' EPS (Basic) plummeted by 67605.89% in 2020, and later surged by 6246.25% in 2023.
- Quarter analysis of 4 years shows Solid Biosciences' EPS (Basic) stood at -$6.17 in 2020, then surged by 88.98% to -$0.68 in 2022, then tumbled by 47.06% to -$1.0 in 2023, then dropped by 2.0% to -$1.02 in 2024.
- Its EPS (Basic) stands at -$1.02 for Q4 2024, versus -$0.79 for Q3 2024 and -$0.61 for Q2 2024.